Cefpodoxime (as proxetil) 50 mg / 5 ml - Cefpodoxime (as proxetil) 100 mg.

Dry Syrup 60 ml / 10 Film Coated Tablets.

3rd generation cephalosporine.




Oraluxe® (Cefpodoxime Proxetil) is an orally administered, extended spectrum semi-synthetic antibiotic of the cephalosporin class, belonging to the third generation.
The bactericidal activity of Oraluxe results from its inhibition of cell wall synthesis. Cefpodoxime has a high degree of stability in the presence of beta-lactamases, both penicillinases and cephalosporins of gram-negative and gram-positive bacteria.

Oraluxe® is recommended in adults and in children (age 5 months through 12 years) for treatment of the following infections:
- Tonsillitis, pharyngitis, sinusitis and otitis media.
- Acute, community acquired pneumonia, acute purulent bronchitis, acute bacterial exacerbation of chronic obstructive bronchitis.
- Acute, uncomplicated urethra and cervical gonorrhea caused by (neisseria gonorrhoeae).
- Acute, uncomplicated anorectal infections in women due to (neisseria gonorrhoeae).
- Uncomplicated urinary tract infections (cystitis).
- Uncomplicated skin and skin structure infections.

Aleppo Pharmaceutical Company (ALPHA) is Syria's leading manufacturer and distributor of pharmaceutical products. Providing high quality products according to GMP requirements; regulations and ISO 9002 (Quality Management System).

Syrian Pharmaceutical Industries, Middle East, Syria Pharmaceutical Industry, pharmacy, Medicaments, medical, Drugs, arab pharmaceutical manufacturing, pharmaceutical companies, pharmaceutical sales.

If you have any questions about Oraluxe® that have not been answered on this site send us an email or call ALPHA Pharmaceutical Industry at + 963-21-2122424.

Copyright © ALPHA – Aleppo Pharmaceutical Industries, Aleppo-Syria - Oraluxe®. All rights reserved
Web Design by Syrian Web Solutions